Position in OPK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$460,968
+$331,487 QoQ
Shares Held
404,358
+293.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OPK Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $924,641,036 across 18 Diagnostics & Research names. OPK ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,280,319 | $259,910,759 | |
| 2 | DHR |
Danaher Corp /De/
|
1,348,956 | $255,762,057 | |
| 3 | DGX |
Quest Diagnostics Inc
|
734,714 | $143,989,249 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
188,774 | $92,788,084 | |
| 5 | NTRA |
Natera, Inc.
|
306,300 | $61,256,937 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
85,650 | $48,125,878 | |
| 7 | CSTL |
Castle Biosciences Inc
|
559,583 | $13,737,762 | |
| 8 | QGEN |
Qiagen N.V.
|
313,960 | $12,570,958 |
All Filings in OPK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $460,968 | 404,358 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $129,481 | 102,763 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $112,131 | 74,259 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $120,208 | 75,130 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $263,271 | 210,617 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $57,026 | 30,173 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $107,985 | 27,338 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $84,807 | 22,983 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $39,801 | 11,672 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||